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ABSTRACT: Aims: To describe the prevalence and intensity of different
symptoms  in  relation  to  tobacco  abstinence.  To  explore  latent  dimensions
between symptoms in smokers trying to quit.  Design: A cross sectional study
using a questionnaire to retrospectively assess symptoms over a period of 12
months.  Setting: Swedish telephone quitline, a nationwide free of charge service.
Participants: All 741 individuals who had called the quitline and signed up for
smoking cessation treatment between February 2000 to November 2001 and
reported to have been smoke free for at least 24 hours during the previous 12
month period from first contact.   Measurements: Assessments were made by
self-report, and abstinence was defined as “not a single puff of smoke during the
last week”. A factor analysis approach where individual items aggregate into
factors was used to explore the relationship between the different symptoms.
Findings: High intensity of symptoms related to unsuccessful quitting attempts
and included craving, irritability, apprehension/anxiety, difficulties concentrating,
restlessness, depression/ depressed mood, and insomnia. The factor loadings of all
17 symptoms resulted in three factors with factor 1, psychological being the most
important. High scores on this factor relates to unsuccessful quitting attempts.
Using Nicotine Replacement Therapy (NRT) for 5 weeks or longer, reduced
symptoms included in factor 1. The other two factors were factor 2 physiological
and factor 3 neurological.  Conclusions: Symptoms that are psychological and/or
neurological in nature are interrelated and appear to be the most significant
obstacles for successful quitting attempts in a population-based setting. These
symptoms may be successfully treated with NRT.
KEYWORDS:  Smoking  cessation,  quit  rate,  factor  analysis,  withdrawal,
symptoms.
INTRODUCTION
Many  who  try  to  quit  smoking
relapse within the first week [1, 2] and
90 percent who attempt to stop smoking
without support, relapse within one year
[3, 4]. Although most of our knowledge
stems from closely monitored clinical
drug trials, the understanding of why a
majority  of  attempts  to  stop  smoking
fail, is incomplete.
One factor that may explain a failed
quit attempt is the smoker’s experience
of nicotine withdrawal. Early relapsing
smokers are thought to be more severely
dependent, and smokers unable to stay
quit  have  reported  more  severe
withdrawal symptoms [5, 6].Symptoms in smokers trying to quit 45
Although  studies  have  focused  on
different  symptoms  and  varying
definitions of severity, they are generally
consistent with the American Psychiatric
Association  Diagnostic  and  the
Statistical Manual definition of nicotine
withdrawal  DSM-IV  [7].  Nicotine
withdrawal  includes  symptoms  of
anxiety/apprehension,  restlessness,
difficulty  concentrating,
depression/depressed mood, irritability,
sleepiness/drowsiness, and insomnia [7].
Despite  omission  from  the  DSM-IV,
craving  is  also  a  cardinal  feature  of
sudden abstinence from nicotine use.
We  hypothesise  that  respondents
who are failed quitters in a telephone
quitline report more severe symptoms
compared with subjects who succeed in
stopping smoking. This should hold even
after  controlling  for  potential
confounders including age, gender, and
use  of  nicotine  replacement  therapy
(NRT).  We  also  hypothesise  that
depression/depressed  mood  may  be
associated  with  failure  to  remain
abstinent. The objective of this study
was  to  describe  the  prevalence  and
intensity  of  different  symptoms  in
relation to tobacco abstinence in a group
of quitters calling a quitline. We also try
to  explore  if  there  is  a  correlation
between the different symptoms.
MATERIAL AND METHODS
Study population and setting
The study is based on a 12-month
follow-up comprising all 1131 smokers
who had called the Swedish quitline and
signed  up  for  smoking  cessation
treatment  from  February  2000  to
November 2001. A total of 741 people
(66%) reporting to have been abstinent
for  a  minimum  of  24  hours  to  a
theoretical  maximum  of  12  months
during  the  follow-up  period  were
included in the study base. The same
study  population  was  used  for  all
analyses.
The  Swedish  quitline  [8,  9]  is  a
nationwide free of charge service that
operates  51  hours  per  week  through
three to four telephone lines. All calls
are registered on computerised patient
records.  All  callers  signing  up  for
smoking cessation support by returning a
registration form by mail are included.
Self  reported  point  prevalence
abstinence at 12 months was defined as
“not a single puff of smoke during the
last week”.
Measures
A  questionnaire  identifying  17
symptoms  was  sent  by  mail  to  all
subjects 12-13 months after first contact
with the quitline. Assessed symptoms
are  presented  in  Table  1  and  nine
correspond  to  the  Diagnostic  and
Statistic Manual for Mental Disorders
DSM-III-R [10] /DSM – IV criteria [7].
Increased appetite and weight gain were
excluded  because  of  the  narrow  time
window used. Physiological symptoms
not  included  in  the  DSM  comprised
nightmares,  dizziness,  mouth  ulcers,
sweating,  muscular  pain,  cramps,
constipation and other stomach trouble.
The  question  used  to  assess
symptoms was: “Did you experience any
of the symptoms listed below when you
abstained from smoking? -Reply to this
question only if you have been abstinent
for at least 24 h since your first contact
with the quitline”.
For self-assessment of symptoms we
used: none,  low,  moderate,  and  high
[11]. One additional question was asked
to  explore  if  those  having
depression/depressed  mood  as  a
symptom were more prone to relapse
“Have you been unusually stressed or46 Tomson T, Toftgård M, Gilljam H, Helgason AR
depressed during any period after your
first contact with the quitline?”.
NRT use was assessed by asking the
question  ”which  of  the  following
nicotine replacement products did you
use  after  your  first  contact  with  the
quitline?”.  Pharmacological  treatment
included:  chewing  gum,  transdermal
nicotine patch, inhaler, nasal spray or
tablets.
Ethical  approval  was  obtained  by
Karolinska Institutet (Dnr 00-367).
Statistical methods and presentation of
data
Logistic regression analysis was used
to  calculate  crude  and  adjusted  odds
ratios with 95% confidence interval. To
analyse  the  relationship  between
symptoms  and  abstinence  we
dichotomised the response alternatives
(none, low, moderate, and high) into low
and high intensity. This was done so that
for  each  variable,  the  two  categories
became as equally sized as possible. The
cut-offs for the assessment of NRT use
were “less than 5 weeks”, “5 weeks or
more”, or “not at all”. NRT was also
assessed as “NRT” vs. “no NRT use”.
Significance  levels  for  all  tests  were
two-tailed.  Statistical  analysis  was
carried out using the Statistical Package
for the Social sciences (SPSS 12.1).
A  factor  analysis  approach  where
individual items aggregate into factors
was  used  to  explore  the  relationship
between the different symptoms. Firstly,
a  principal  component  analysis  was
conducted  to  explore  the  correlation
between  the  17  symptoms.  Secondly,
varimax orthogonal rotation was done to
simplify the interpretation of the factors
by  maximising  the  variance  of  the
loadings within factors, across variables.
It was decided a priori that the number
of factors in the varimax rotation should
be based on the number of Eigenvalues
≥  1,0  in  the  principal  component
analysis  and  Cattell’s  scree  test  was
performed [12, 13, 14]. Factor loadings
greater than 0.35 was a priori considered
to be of importance when interpreting
the factors.
A factor loading matrix is created
were correlations between factors and
variable are presented. The first column
is correlations between the first factor
and each variable in turn. The second
column  is  correlations  between  the
second factor and each variable in turn
and goes on the same way for the third
factor. A factor is interpreted from the
variables that are highly correlated with
it – that have high loadings on it [14].
To assess the relationship between
factors  and  abstinence,  factor  scores
were  calculated  using  the  regression
method and t-test was performed.
RESULTS
Prevalence of symptoms
Of the 1131 subjects who agreed to
participate in the study, 66% (741/1131)
reported  to have been smoke free for at
least 24 hours. Of those 741, fourteen
(2%)  reported  no  symptoms  (not  in
table). The description of all symptoms
are given in Table 1. A total of 43%
reported to have high craving and 34%
reported  high  restlessness.  Other
relevant  symptoms  were  reported  by
approximately  one  in  four  subjects:
apprehension/anxiety  25%,  irritability
24%, difficulties concentrating 24%, and
depression/depressed mood 24% (Table
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TABLE 1 Frequency and intensity of reported symptoms in smokers abstaining from
tobacco at least 24 hours. (N=741)
Symptoms  No
%        n
Low
%        n
Moderate
%        n
High
%        n
Craving 12%  (91) 15% (115) 29% (215) 43% (320)
Irritability 24% (177) 25% (185) 27% (203) 24% (176)
Apprehension/
Anxiety
27% (200) 24% (175) 25% (182) 25% (184)
Restlessness 18% (135) 21% (156) 27% (199) 34% (251)
Difficulties
concentrating
29% (216) 23% (168) 24% (181) 24% (176)
Depression/
depressed mood
35% (261) 20% (151) 21% (153) 24% (176)
Headache 61% (450) 18% (137) 13% (94)   8%   (60)
Insomnia 46% (341) 18% (137) 15% (111) 20% (152)
Sleepiness/drowsiness 61% (450) 17% (128) 12% (91) 10% (72)
Nightmares 71% (526/) 12% (89)   9% (64)   8% (62)
Dizziness 66% (493) 17% (130)   9% (64)   7% (54)
Mouth ulcers 81% (601)   7% (55)   5% (35)   7% (50)
Sweating 58% (429) 16% (119) 14% (107) 12% (86)
Muscular pain 76% (562) 12% (90)   6% (45)   6% (44)
Cramps 88% (650)   5% (41)   4% (27)   3% (23)
Constipation 70% (519) 12% (89)   8% (62) 10% (71)
Other stomach trouble 75% (558) 11% (85)   8% (56)   6% (42)48 Tomson T, Toftgård M, Gilljam H, Helgason AR
Abstinence
Of  all  subjects  48%  (354/741)
reported not a single puff of smoking
during  the  previous  week  (point
prevalence abstinence). There was no
significant  difference  regarding  the
prevalence  of  symptoms  when
comparing those being smoke free for at
least 24 hours with those being abstinent
for  seven  days,  two  months  or  six
months  (not  in  table).  The  observed
relationship  between  symptoms  and
abstinence  remained  even  after
adjustment for age, gender, and use of
nicotine  replacement  therapy  (not  in
table).   Of  those  having  depression/
depressed mood 28% (184/649) reported
abstinence  compared  with  72%
(465/649) not being abstinent OR (1.4 -
1.8).
NRT use
NRT was used by 80% (592/741). Of
those reporting NRT use 34% (199/592)
were  smoke  free  compared  to  27%
(121/446)  of  subjects  reporting  not
having used NRT, OR 1.4 (1.0-1.8), (not
in table). Of people using NRT for 5
weeks or longer 48% (115/237) reported
to  be  smoke  free,  compared  to  27%
(121/446) in those who did not use NRT,
OR 2.5 (1.8-3.5), (not in table). When
the  analysis  was  restricted  to  include
only  people  reporting  having  been
smoke free for at least 5 weeks, those
using NRT were less likely to be point-
prevalence smoke free 54% (171/317)
vs. 65% (121/186) OR 0.6 (0.4-0.9), (not
in table).
High intensity of symptoms related
to  unsuccessful  quitting  attempts  and
comprised  craving,  irritability,
apprehension/anxiety,  difficulties
concentrating, restlessness, depression/
depressed mood and insomnia. A reverse
relation was observed for mouth ulcers
(Table 2).
Factor analysis
Three  factors  whose  eigenvalues
(i.e.,  the  sum  of  the  squared  factor
loadings)  were  greater  than  1  were
identified and accounted for 49% of the
variance.  Factor  loading  greater  than
0.35 was considered in the interpretation
of the factors (Table 3). The greater the
loading,  the  more  the  variable  is
considered a pure measure for the factor
[15].  Factor  1 (psychological)
comprised symptoms that were mainly
psychological  and  to  some  extent
neurological in nature. Assigned to this
group  were  craving,  irritability,
apprehension/anxiety,  difficulties
concentrating (also included in factor 3),
restlessness, and depression/ depressed
mood (also included in factor 3), (Table
3). Factor  2 (physiological)  included
symptoms that were primarily physical
(somatic)  and  partly  neurological
including mouth ulcers, dizziness, (also
included in factor 3) sweating, muscular
pain,  cramps,  constipation,  and  other
stomach  trouble  (Table  3).  Factor  3
(neurological)  comprised  mainly
symptoms  that  may  be  termed
neurological as well as some symptoms
that are more psychological in nature
including  headache,  insomnia,
sleepiness/drowsiness,  nightmares,
dizziness, difficulties concentrating (also
included in factor 1), and depression/
depressed mood (also included in factor
1), (Table 3).
Factor scores and abstinence
The comparison between the mean
values of the factor scores revealed that
a  high  factor  score  on  factor  1
(psychological) was significantly related
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TABLE 2 Withdrawal symptoms versus abstinence. Presenting percentage and
proportion reporting to be abstinent. (N=741)
Symptoms Low intensity High
intensity
(ref)
 OR  95%CI
#
Craving 49% (207/421) 32% (103/320)    2.0  1.5-2.8*
Irritability 45% (163/362) 39% (147/379)    1.3  1.0-1.7*
Apprehension/
Anxiety
47% (177/375) 36% (133/366)    1.6  1.2-2.1*
Restlessness 49% (142/291) 37% (168/450)    1.6  1.2-2.2*
Difficulties
concentrating
46% (175/384) 38% (135/357)    1.4  1.0-1.8*
Depression/depressed
 mood
48% (196/412) 35% (114/329)    1.7  1.3-2.3*
Headache 40% (182/450) 44% (128/291)    0.9  0.6-1.2
Insomnia 45% (155/341) 39% (155/400)    1.3  1.0-1.8*
Sleepiness/drowsiness 41% (186/450) 43% (124/291)    0.9  0.7-1.3
Nightmares 42% (222/526) 41% (88/215)    1.1  0.8-1.5
Dizziness 42% (206/493) 42% (104/248)    1.0  0.7-1.4
Mouth ulcers 40% (238/601) 51% (72/140)    0.6  0.4-0.9*
Sweating 42% (180/429) 42% (130/312)    1.0  0.8-1.4
Muscular pain 41% (233/562) 43% (77/179)    0.9  0.7-1.3
Cramps 41% (269/650) 45% (41/91)    0.9  0.6-1.3
Constipation 43% (222/519) 40% (88/222)    1.1  0.8-1.6
Other stomach trouble 41% (227/558) 45% (83/183)    0.8  0.6-1.2
Note: Dichotomisation was done so that for each symptom, the two categories became as equally sized as
possible
* Difference statistically significant
# Crude odds ratios with 95% confidence interval50 Tomson T, Toftgård M, Gilljam H, Helgason AR
TABLE 3 Factor analysis including items of distinctive groups, psychological,
physiological and neurological.
                                    Factor
1 2 3
Craving .701 .176 -.238
Irritability .714 .090 .175
Apprehension/anxiety .741 .045 .328
Restlessness .738 .085 .220
Difficulties concentrating .713 .085 .367
Depression/depressed mood .546 .046 .444
Headache .182 .192 .647
Insomnia .257 .195 .625
Sleepiness/drowsiness .136 .209 .633
Nightmares .155 .274 .576
Dizziness .107 .453 .432
Mouth ulcers .056 .583 .080
Sweating .209 .575 .317
Muscular pain .047 .693 .151
Cramps .053 .726 .017
Constipation .093 .533 .205
Other stomach trouble .037 .526 .276
Note: Factor loadings greater than 0.35 are boldface and constitute a relationship defining a factor
NRT and symptoms
When compared with those reporting not
having  used  nicotine  replacement
therapy (NRT), using NRT for less than
5  weeks  was  significantly  correlated
with an increased prevalence of craving,
irritability, difficulties concentrating and
mouth  ulcers,  and  a  decreased
prevalence of cramps (Table  4).  With
exception  of  mouth  ulcers  these
correlations  did  not  remain  when
comparing non-users of NRT to users of
NRT  for  5  weeks  or  longer.  The
tendency  of  increased  prevalence  for
users of NRT for less than 5 weeks, but
not for users of NRT for 5 weeks or
longer,  was  seen  for  all  symptoms
comprising  the  psychological  factor
(Figure  1).  Constipation  and  other
stomach  trouble  showed  yet  another
pattern with an increase of prevalence
for users of NRT for 5 weeks or longer
but not for users of NRT for less than 5
weeks (Table 4). Of all NRT users those
using  chewing  gum  reported  more
ulceration compared  with  those  using
non-oral  NRT,  24%  (53/216)  versus
18% (40/227), OR 1.5 (1.0-2.4) (not in
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TABLE 4 How NRT is related to different symptoms N=625
Symptoms Ref No NRT
#     NRT<5 weeks          NRT ≥5 weeks
Craving 36% (88/242) 53% (98/185)
2.0 (1.3-2.9)*
42% (83/198)
1,3 (0.9-1.9)
Irritability 48% (117/242) 60% (111/185)
1.6 (1.1-2.4)*
47% (94/198)
1.0 (0.7-1.4)
Apprehension/
anxiety
51% (123/242) 57% (106/185)
1.3 (0.9-1.9)
45% (89/198)
0.8 (0.5-1.2)
Restlessness 56% (136/242) 63% (116/185)
1.3 (0.9-1.9)
61% (120/198)
1.2 (0.8-1.8)
Difficulties concentrating
44% (107/242) 55% (101/185)
1.5 (1.0-2.2)*
46% (92/198)
1.1 (0.8-1.6)
Depression/depressed
mood
43% (103/242) 47% (87/185)
1.2 (0.8-1.8)
41% (82/198)
1.0 (0.7-1.4)
Headache 38% (91/242) 43% (80/185)
1.3 (0.9-1.9)
38% (76/198)
1.0 (0.7-1.5)
Insomnia 49% (118/242) 54% (99/185)
1.2 (0.8-1.8)
56% (111/198)
1.3 (0.9-2.0)
Sleepiness/drowsiness 39% (94/242) 41% (76/185)
1.1 (0.7-1.6)
39% (78/198)
1.0 (0.7-1.5)
Nightmares 28% (67/242) 27% (50/185)
1.0 (0.6-1.5)
32% (64/198)
1.2 (0.8-1.9)
Dizziness 35% (85/242) 35% (64185)
1.0 (0.7-1.5)
32% (64/198)
0.9 (0.6-1.3)
Mouth ulcers 15% (36/242) 22% (41/185)
1.6 (1.0-2.7)*
24% (47/198)
1.8 (1.1-2.9) *
Sweating 40% (96/242) 45% (83/185)
1.2 (0.8-1.8)
41% (82/198)
1.1 (0.7-1.6)
Muscular pain 26% (62/242) 23% (43/185)
0.9 (0.6-1.4)
23% (46/198)
0.9 (0.6-1.4)
Cramps 15% (35/242) 6% (11/185)
0.4 (0.2-0.8)*
15% (29/198)
1.0 (0.6-1.7)
Constipation 26% (62/242) 29% (53/185)
1.2 (0.8-1.8)
35% (69/198)
1.6 (1.0-2.3) *
Other stomach trouble 21% (52/242) 25% (47/185)
1.2 (0.8-1.9)
29% (58/198)
1.5 (1.0-2.3) *
Note: Dichotomisation was done so that for each symptom, the two categories became as equally sized as
possible
# Crude odds ratios with 95% confidence interval comparing with no NRT use
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Trend of withdrawal symptoms
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Figure 1 Symptoms in relation to NRT use. Presenting odds ratios for high intensity of
different symptoms in relation to NRT use.
DISCUSSION
Three factors of symptoms reported
to be related to tobacco abstinence were
identified  among  this  group  of
consecutive  callers  to  the  Swedish
quitline  (Table 3): “psychological”
(factor 1), “physiological” (factor 2),
and  “neurological”  (factor  3).  The
symptoms  that  were  most  frequently
reported (Table 1) were the symptoms
comprising  what  we  labelled  as  the
psychological  factor.  All  symptoms
comprising  the  psychological  factor
were  statistically  related  to  point
prevalence abstinence at 12 months, with
those  reporting  low  intensity  of  the
symptoms being more likely to report
abstinence.
Symptoms  and  abstinence:  All
symptoms comprising the psychological
factor were negatively related to point
prevalence abstinence at 12 months. This
factor  comprised  largely  the  same
symptoms  that  have  previously  been
highlighted in the assessment of tobacco
cessation in other settings [16, 17] and
related to abstinence [18, 19, 20]. Three
prospective  studies  have  reported
depression/depressed  mood  as  being
predictive  of  unsuccessful  smoking
cessation and relapse [21, 20, 22]. This
is in line with our results where having
depression/depressed  mood  as  a
symptom proved to be associated with
failure to remain abstinent. Also in table
2  having  high  intensity  of
depression/depressed  mood  related
negatively to abstinence. (Table 2).Symptoms in smokers trying to quit 53
In our study, only two symptoms not
belonging to the psychological factor,
were related to abstinence: insomnia and
mouth ulcers. Insomnia included in the
neurological factor (factor 3) in Table 3
was one of three symptoms assessing
sleeping disorders that comprised half of
the symptoms in this factor. Studies of
nicotine  withdrawal  have  consistently
found sleep disturbance to be a common
complaint [23] and since three of the
symptoms  insomnia,
sleepiness/drowsiness  and  nightmares
related  to  sleep  disturbance  and  had
relatively high factor loadings we might
have  a  latent  dimension  of  sleeping
disorders in factor 3.
The other symptom not belonging to
the  psychological  factor,  and
significantly related to abstinence was
mouth  ulcers,  belonging  to  the
physiological factor (factor 2) in Table
3.  In  this  case  the  relationship  was
reverse. Subjects reporting mouth ulcers
were more likely to be abstinent. This
might be explained by the fact that NRT
use  was  positively  related  to  mouth
ulcers. In our study, high intensity of
mouth  ulcers  was  reported  by  7%.
Another study found that 8% reported
severe mouth ulcers [24] in relation to
smoking cessation.
It has been reported that one in ten
patients  has  severe  problems  with
constipation  in  relation  to  smoking
cessation [25]. This was confirmed in
our results.
Symptoms and NRT:
  All  psychological  symptoms
appeared to be associated with NRT use.
People using NRT for less then 5 weeks
reported a higher prevalence of these
symptoms  compared  with  individuals
not using NRT and those who used NRT
for 5 weeks or longer.
It  would  be  expected  that  people
experiencing  low  intensity  of  these
symptoms would be less prone to use
NRT.  Figure  1  illustrates  that  people
using  NRT  to  ease  psychological
symptoms need taking higher doses to
achieve results. These findings are in
line  with  previous  reports  [26]  and
present  recommendations  regarding
NRT  [27].  There  was  a  significant
increase of mouth ulcers in NRT users
compared  with  non-users.  One
hypothesis is that this may be due to a
changed balance in oral microbial flora
secondary to the toxic effect of nicotine.
NRT and abstinence:
  The  hypothesis  that  nicotine
withdrawal may be an important reason
why individuals persist in their smoking
behaviour  and  are  relatively
unsuccessful in their smoking cessation
attempts [28, 29] is supported by our
results.  That  can  be  seen  by  the
relationship between low prevalence of
symptoms comprising the psychological
factor,  increased  abstinence  and  the
suppressing  effect  of  NRT  use  for  5
weeks or longer on these symptoms.
However, the relationship  between
nicotine  withdrawal  and  unsuccessful
smoking cessation has been ambiguous
in previous reviews of the literature [30].
One reason for this unclear relationship
may  be  insufficient  control  for
psychological and environmental factors
strongly related to abstinence [8]. These
psychological and environmental factors
will  delude  the  relationship  between
nicotine  dependency  and  successful
cessation if not controlled for. Also, the
assessment  of  dependence  usually
comprises questionnaires that should at
best  be  viewed  as  indicators  of
dependence  and  are  by  no  means
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phenomenon [31]. There is a possibility
of unidentified physiological factors of
dependence in tobacco that may partly
be  responsible  for  the  diffuse
relationship  between  nicotine
withdrawal and unsuccessful smoking
cessation. However, such a hypothesis is
highly speculative. However, the risk of
experiencing nicotine withdrawal after a
quit attempt is known to be partly related
to genetic vulnerability [18].
Gender  has  been  reported  to
influence withdrawal  discomfort [32].
However, other studies, including ours,
found  no  differences  in  overall
withdrawal severity between men and
women [17, 23, 32].
Methodological limitations:
  The  present  study  assesses  a
population of smokers having called a
quitline for smoking cessation support.
We  do  not  know  if  those  not
participating in the follow-up (30%) had
more withdrawal symptoms. However,
in a previously published study [33] we
assessed  the  behaviour  of  non-
responders  by  using  telephone
interviews with a sample of people not
participating in the 12 months follow-up.
No  significant  difference  regarding
abstinence rates between responders and
non-responders  was  found  in  our
material.
Another  possible  source  of  error
includes the use of single item measures
of symptoms, rating each symptom on a
four point prevalence intensity scale [34,
35]. An alternative would have been to
use  validated  psychometric  scales  to
assess the prevalence and intensity of
symptoms  like  anxiety  and
depression/depressed  mood.  This  was
not  deemed  practical  in  the  quitline
setting  due  to  the  large  number  of
patients.
As most smokers report multiple quit
attempts before they succeed [36] it is
plausible  that  individuals  eventually
learn  to  endure  the  symptoms  of
withdrawal.  Thus,  the  reported
symptoms  (Table  1)  may  be  an
underestimation. Also, coping strategies
such  as  relaxation  or  seeking  social
support which may have been achieved
through  the  quitline  counsellors,  may
have  moderated  symptom  stress.
Another caveat in a retrospective study
is recall bias.
The  questionnaire  used  by  the
Swedish quitline at the time assessed
withdrawal  symptoms  only  among
smokers who had made a serious attempt
to quit and had been totally tobacco free
for at least 24 hours. Thus, comparing
symptoms  between  smokers  not
attempting to quit and those who were at
least temporary successful (24 hours or
more) was not possible. Further, we do
not know the prevalence and intensity of
the assessed symptoms in the general
population  of  non  smokers.  Thus,
baseline data on the prevalence of the
symptoms was not available which is a
problem for the presentation of symptom
prevalence in Table 1. However, this is
probably not a major problem for the
analysis  of  the  relationship  between
symptoms  and  to  what  extent  the
reported symptoms were related to the
12 months abstinence rate.
It has been argued that a quit attempt
that lasted a week or longer in the last
year appears less biased by recall than
any attempt of a day or longer in the last
year [37]. However, the 24 hour time
frame of abstinence used for symptom
assessment  was  selected  to  achieve
better statistical power in the analysis. It
may be argued that the 24 hour time
window is too narrow but we argue that
this  is  justifiable  since  there  was  noSymptoms in smokers trying to quit 55
significant difference detected regarding
prevalence of symptoms in the 24 hour
group  when  compared  with  people
reporting longer abstinence (seven days,
two and 6 months). It was noted [1] that
self-report  ratings  of  behaviours  and
internal states becomes less valid when
participants are asked to rate them over a
substantial  period  of  time  (i.e.  2-4
weeks) rather than a shorter time period
(i.e. within the past 24 hrs.).
Unfortunately only abstinent subjects
were examined since the question only
addressed those being abstinent for at
least 24 h. This may have understated
symptom severity.
NRT  was  measured  only  with  a
question assessing duration of treatment
and the cut-offs were less than 5 weeks,
5 weeks or more, or not at all. There was
no measure of the intensity of the NRT
treatment  during  the  assessed  time
frame.  This  is  likely  to  reduce  the
sensitivity of assessment of the impact
NRT may have on the severity of the
symptoms.
Although the 17 symptoms measured
here  fell  almost  cleanly  into  three
distinct groupings, this does not mean
that  there  are  only  three  factors  of
symptoms related to tobacco withdrawal.
There may be other factors not captured
by  these  17  items.  Additional  studies
need to be done to further explore the
mechanisms  that  produce  the  three
factors observed in this study.
In conclusion, our results indicate
that  high  prevalence  of  symptoms
comprising  the  psychological  factor
relate to unsuccessful quitting attempts
in  a  population-based  setting.  NRT
appeared to have a positive effect on
relieving these symptoms when used for
five weeks or more.
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